Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Long-Term Debt Repayments: 2011-2025

Historic Long-Term Debt Repayments for Adma Biologics (ADMA) over the last 4 years, with Sep 2025 value amounting to $2.5 million.

  • Adma Biologics' Long-Term Debt Repayments fell 91.67% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.1 million, marking a year-over-year decrease of 18.88%. This contributed to the annual value of $60.0 million for FY2024, which is 62.17% down from last year.
  • Adma Biologics' Long-Term Debt Repayments amounted to $2.5 million in Q3 2025, which was down 91.67% from $30.0 million recorded in Q4 2024.
  • Adma Biologics' Long-Term Debt Repayments' 5-year high stood at $158.6 million during Q4 2023, with a 5-year trough of $2.5 million in Q3 2025.
  • Over the past 3 years, Adma Biologics' median Long-Term Debt Repayments value was $30.0 million (recorded in 2024), while the average stood at $55.3 million.
  • Data for Adma Biologics' Long-Term Debt Repayments shows a maximum YoY slumped of 91.67% (in 2025) over the last 5 years.
  • Adma Biologics' Long-Term Debt Repayments (Quarterly) stood at $100.0 million in 2022, then reached $158.6 million in 2023, then crashed by 81.08% to $30.0 million in 2024, then crashed by 91.67% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $30.0 million for Q4 2024, and $30.0 million during Q3 2024.